11569
3,4-Dihydroxyphenylacetic acid
analytical standard
동의어(들):
DOPAC, Homoprotocatechuic acid
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
제품정보 (DICE 배송 시 비용 별도)
Linear Formula:
(HO)2C6H3CH2CO2H
CAS 번호:
Molecular Weight:
168.15
UNSPSC Code:
77101502
NACRES:
NA.24
PubChem Substance ID:
EC Number:
203-024-1
Beilstein/REAXYS Number:
2211017
MDL number:
InChI
1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)
InChI key
CFFZDZCDUFSOFZ-UHFFFAOYSA-N
SMILES string
OC(=O)Cc1ccc(O)c(O)c1
grade
analytical standard
assay
≥97.0% (HPLC), 97.0-103.0% (T)
shelf life
limited shelf life, expiry date on the label
technique(s)
HPLC: suitable, gas chromatography (GC): suitable
mp
127-130 °C (lit.)
application(s)
pharmaceutical
format
neat
Quality Level
유사한 제품을 찾으십니까? 방문 제품 비교 안내
Application
3,4-Dihydroxyphenylacetic acid may be used as a reference standard for the determination of 3,4-dihydroxyphenylacetic acid in rat samples by high-performance liquid chromatography with electrochemical detection.
Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2
저장 등급
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Simultaneous determination of 3, 4?dihydroxyphenylalanine, 5?hydroxytryptophan, dopamine, 4?hydroxy?3?methoxyphenylalanine, norepinephrine, 3, 4?dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5?hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high?performance liquid chromatography with electrochemical detection.
Wagner J, et al.
Journal of Neurochemistry, 38(5), 1241-1254 (1982)
Jinhee Kim et al.
Biomolecules & therapeutics, 28(3), 282-291 (2020-04-28)
Inhaled solvents such as toluene are of particular concern due to their abuse potential that is easily exposed to the environment. The inhalation of toluene causes various behavioral problems, but, the effect of short-term exposure of toluene on changes in
Wanqiu Huang et al.
Journal of neurochemistry, 150(3), 282-295 (2019-05-24)
Neuroinflammation is one of the driving forces of progressive neurodegeneration in Parkinson's disease (PD). The metabolomics approach has been proved highly useful in identifying potential therapeutic targets. Here, to identify inflammation-relevant treatment targets for PD, mass spectrometry-based untargeted metabolomics was
Sandy Stayte et al.
PloS one, 10(4), e0124325-e0124325 (2015-04-23)
Parkinson's disease (PD) is a chronic neurodegenerative disease characterized by a significant loss of dopaminergic neurons within the substantia nigra pars compacta (SNpc) and a subsequent loss of dopamine (DA) within the striatum. Despite advances in the development of pharmacological
Bing Han et al.
Parkinsonism & related disorders, 20(11), 1191-1195 (2014-09-16)
Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that is caused predominantly by the degeneration of the nigrostriatal dopaminergic pathway. Lateral habenula (LHb) has efferent projections that terminate in the substantia nigra pars compacta (SNpc) and electrical stimulation of
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.